A phenome-guided drug repositioning through a latent variable model

作者: Halil Bisgin , Zhichao Liu , Hong Fang , Reagan Kelly , Xiaowei Xu

DOI: 10.1186/1471-2105-15-267

关键词: Latent Dirichlet allocationGenerative modelLatent variable modelPhenomeLatent variableDrug repositioningData miningPopulationBiologyProbabilistic logic

摘要: The phenome represents a distinct set of information in the human population. It has been explored particularly its relationship with genome to identify correlations for diseases. also drug repositioning efforts focusing on search space most similar candidate drugs. For comprehensive analysis phenome, we assumed that all phenotypes (indications and side effects) were inter-connected probabilistic distribution this characteristic may offer an opportunity new therapeutic indications given drug. Correspondingly, employed Latent Dirichlet Allocation (LDA), which introduces latent variables (topics) govern distribution. We developed our model Side Effect Resource (SIDER). first LDA optimized based recovery potential through perturbing drug-phenotype matrix each drug-indication pairs where was switched “unknown” one at time then recovered remaining pairs. Of probabilistically significant pairs, 70% successfully recovered. Next, applied whole narrow down candidates suggest alternative indications. able retrieve approved 6 drugs whose not listed SIDER. 908 present their indication information, suggested treatment options further investigations. Several uses can be supported from scientific literature. results demonstrated analyzed by generative model, discover associations between uses. In regard, serves as enrichment tool explore existing narrowing space.

参考文章(43)
CY Loo, HJ Tan, HS Teh, AA Raymond, None, Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. Singapore Medical Journal. ,vol. 48, pp. 834- 839 ,(2007)
David M Blei, Andrew Y Ng, Michael I Jordan, None, Latent dirichlet allocation Journal of Machine Learning Research. ,vol. 3, pp. 993- 1022 ,(2003) , 10.5555/944919.944937
Ilona Kaczmarczyk-Sedlak, Joanna Folwarczna, Henryk I. Trzeciak, Thalidomide affects the skeletal system of ovariectomized rats Pharmacological Reports. ,vol. 61, pp. 529- 538 ,(2009) , 10.1016/S1734-1140(09)70096-9
Kaczmarczyk-Sedlak Ilona, Zych Maria, Rotko Katarzyna, Sedlak Lech, Effects of thalidomide on the development of bone damage caused by prednisolone in rats. Pharmacological Reports. ,vol. 64, pp. 386- 395 ,(2012) , 10.1016/S1734-1140(12)70779-X
Zhichao Liu, Hong Fang, Kelly Reagan, Xiaowei Xu, Donna L. Mendrick, William Slikker, Weida Tong, In silico drug repositioning: what we need to know. Drug Discovery Today. ,vol. 18, pp. 110- 115 ,(2013) , 10.1016/J.DRUDIS.2012.08.005
A B Myles, P A Bacon, K A Williams, Mefenamic acid in rheumatoid arthritis. Annals of the Rheumatic Diseases. ,vol. 26, pp. 494- 498 ,(1967) , 10.1136/ARD.26.6.494
Masaaki Deguchi, Yoshiaki Isobe, Shigeru Matsukawa, Akio Yamaguchi, Gizo Nakagawara, Usefulness of metyrapone treatment to suppress cancer metastasis facilitated by surgical stress Surgery. ,vol. 123, pp. 440- 449 ,(1998) , 10.1016/S0039-6060(98)70166-7
Nelson Freimer, Chiara Sabatti, The Human Phenome Project Nature Genetics. ,vol. 34, pp. 15- 21 ,(2003) , 10.1038/NG0503-15
S Kapicioglu, E Gökce, Z Kapicioglu, E Ovali, Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia. ,vol. 17, pp. 27- 30 ,(1997) , 10.1046/J.1468-2982.1997.1701027.X
Lun Yang, Pankaj Agarwal, Systematic Drug Repositioning Based on Clinical Side-Effects PLoS ONE. ,vol. 6, pp. e28025- ,(2011) , 10.1371/JOURNAL.PONE.0028025